Abstract
FOXP2 is a transcription factor expressed in multiple tissues during embryonic development. FOXP2 regulates transcription by binding to DNA at its DNA binding domain, the forkhead domain (FHD) through the recognition helix. Ser557 is a residue located within the recognition helix that has the potential to become phosphorylated posttranslationally. In this study we investigated whether phosphorylation of Ser557 can influence the structure and DNA binding of the FOXP2 FHD. We did this by constructing S557E, a phosphomimetic mutant, and comparing its behaviour to the wild type. The mutation did not affect the secondary or tertiary structure of the protein although it did decrease the propensity of the FOXP2 FHD to form dimers. Most notably, the mutation showed significantly reduced DNA binding compared to the wild type as detected using electrophoretic mobility shift assays. Molecular docking was also performed in which the wild type, phosphomimetic mutant and phosphorylated wild-type were docked to DNA and their interactions with DNA were compared. These results indicated that the wild type forms more interactions with the DNA and that the phosphomimetic mutant as well as the phosphorylated wild type did not associate as favourably with the DNA. This indicates that phosphorylation of Ser557 could disrupt DNA binding likely due to electrostatic and steric hindrance. This suggests that phosphorylation of Ser557 in the FOXP2 FHD could act as a control mechanism for FOXP2 and ultimately could be involved in regulation of transcription.
This is a preview of subscription content, access via your institution.








References
Huffman JL, Brennan RG (2002) Prokaryotic transcription regulators: more than just the helix-turn-helix motif. Curr Opin Struct Biol 12:98–106. https://doi.org/10.1016/S0959-440X(02)00295-6
Latchman S (1997) Transcription factors: an overview. Int J Biochem Cell Biol 29:1305–1312
Benayoun BA, Veitia RA (2009) A post-translational modification code for transcription factors: sorting through a sea of signals. Trends Cell Biol 19:189–197. https://doi.org/10.1016/j.tcb.2009.02.003
Johnson L, Barford D (1993) The effects of phosphorylation on the structure and function of proteins. Annu Rev Biochem 22:199–232
Tootle TL, Rebay I (2005) Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. BioEssays 27:285–298. https://doi.org/10.1002/bies.20198
Wasylyk C, Bradford A, Gutierrez-Hartmann A, Wasylyk B (1997) Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899–913. https://doi.org/10.1038/sj.onc.1200914
Akira S (1997) IL-6-regulated transcription factors. Int J Biochem Cell Biol 29:1401–1418
Friedman JR, Kaestner KH (2006) The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63:2317–2328. https://doi.org/10.1007/s00018-006-6095-6
Clark K, Halay E, Lai E, Burley S (1993) Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364:412–420
Wang B, Lin D, Li C, Tucker P (2003) Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 278:24259–24268. https://doi.org/10.1074/jbc.M207174200
Banham AH, Beasley N, Campo E et al (2001) The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p1. Cancer Res 61:8820–8829
Koh KP, Sundrud MS, Rao A (2009) Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3. PLoS ONE 4:1–9. https://doi.org/10.1371/journal.pone.0008109
Fisher SE, Scharff C (2009) FOXP2 as a molecular window into speech and language. Trends Genet 25:166–177. https://doi.org/10.1016/j.tig.2009.03.002
Spaniel FJ, Horacek J, Tintera I, Ibrahim T, Novak J, Cermak M, Klirova, Hoschl C (2011) Genetic variation in FOXP2 alters grey matter concentrations in schizophrenia patients. Neurosci Lett 493:131–135
Hannenhalli S, Kaestner KH (2009) The evolution of Fox genes and their role in development and disease. Nat Rev Genet 10:233–240
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Witesell L et al (2001) The immune dysregulation polyendocrinopathy enteropathy x-linked syndrome (IPEX) is caused by mutations in FOXP3. Nat Gen 27:20–31
Gong X, Jia M, Ruan Y, Shuang M, Liu J, Wu S, Guo Y, Yang J, Ling Y, Yang X, Zhang D (2004) Association between the FOXP2 gene and autistic disorder in Chinese population. Am J Med Genet B Neuropsychiatry 127B:113–116
Hachigian LJ, Carmona V, Fenster RJ, Kulicke R, Heilbut A, Sittler A, de Almeida P, Mesirov L, Gao JP, Kolaczyk F, E.D. and Heiman M (2017) Control of Huntington’s disease-associated phenotypes by the striatum enriched transcription factor Foxp2. Cell Rep 21:2688–2695
Li S, Weidenfeld J, Morrisey EE (2004) Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24:809–822. https://doi.org/10.1128/MCB.24.2.809
Bandukwala HS, Wu Y, Feuerer M et al (2011) Structure of a domain-swapped FOXP3 Dimer on DNA and its function in regulatory T cells. Immunity 34:479–491. https://doi.org/10.1016/j.immuni.2011.02.017
Stroud JC, Wu Y, Bates DL et al (2006) Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14:159–166. https://doi.org/10.1016/j.str.2005.10.005
Biggs WH, Meisenhelder J, Hunter T et al (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96:7421–7426. https://doi.org/10.1073/pnas.96.13.7421
Zhang X, Gan L, Pan H et al (2002) Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms: Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J Biol Chem 277:45276–45284. https://doi.org/10.1074/jbc.M208063200
Obsil T, Obsilova V (2008) Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27:2263–2275. https://doi.org/10.1038/onc.2008.20
Nie H, Zheng Y, Li R et al (2013) Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med 19:322–328. https://doi.org/10.1038/nm.3085
Berry FB, Tamimi Y, Carle MV et al (2005) The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. Hum Mol Genet 14:2619–2627. https://doi.org/10.1093/hmg/ddi295
Chen YJ, Dominguez-Brauer C, Wang Z et al (2009) A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1. J Biol Chem 284:30695–30707. https://doi.org/10.1074/jbc.M109.007997
Shiromizu T, Adachi J, Watanabe S et al (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the phosphositeplus database as part of the chromosome-centric human proteome project. J Proteome Res 12:2414–2421
Lehtinen MK, Yuan Z, Boag PR et al (2006) A Conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125:987–1001. https://doi.org/10.1016/j.cell.2006.03.046
Brent MM, Anand R, Marmorstein R (2008) Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 16:1407–1416. https://doi.org/10.1016/j.str.2008.06.013
Lowy AM (1996) Mutation of phosphoserine 389 affects p53 function in vivo. J Biol Chem 271:29380–29385. https://doi.org/10.1074/jbc.271.46.29380
Potter LR, Hunter T (1998) Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor. Mol Cell Biol 18:2164–2172
Tarrant MK, Cole PA (2009) The chemical biology of protein phosphorylation. Annu Rev Biochem 78:797–825. https://doi.org/10.1146/annurev.biochem.78.070907.103047
Blane A, Fanucchi S (2015) Effect of pH on the structure and DNA binding of the FOXP2 forkhead domain. Biochemistry 54:4001–4007. https://doi.org/10.1021/acs.biochem.5b00155
Nelson CS, Fuller CK, Fordyce PM et al (2013) Microfluidic affinity and ChIP-seq analyses converge on a conserved FOXP2-binding motif in chimp and human, which enables the detection of evolutionarily novel targets. Nucleic Acids Res 41:5991–6004. https://doi.org/10.1093/nar/gkt259
Webb H, Steeb O, Blane A et al (2017) The FOXP2 forkhead domain binds to a variety of DNA sequences with different rates and affinities. J Biochem 162:45–54. https://doi.org/10.1093/jb/mvx003
Kibbe WA (2007) OligoCalc: an online oligonucleotide properties calculator. Nucleic Acids Res 35:43–46. https://doi.org/10.1093/nar/gkm234
Perumal K, Dirr HW, Fanucchi S (2015) A single amino acid in the hinge loop region of the FOXP Forkhead domain is significant for dimerisation. Protein J 34:111–121. https://doi.org/10.1007/s10930-015-9603-4
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. https://doi.org/10.1002/jcc.20084
DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 newsletter on protein crystallography, 40:82–92
Dominguez C, Boelens R, Bonvin AMJJ. (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125:1731–1737. https://doi.org/10.1021/ja026939x
Chen VB, Arendall WB III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr A D66:12–21
Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB III, Snoeyink J, Richardson JS, Richardson DC (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375-W383
Gasteiger E, Hoogland C, Gattiker A et al (2005) Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook, pp 571–607
Kelly SM, Jess TJ, Price NC (2005) How to study proteins by circular dichroism. Biochim Biophys Acta - Proteins Proteomics 1751:119–139. https://doi.org/10.1016/j.bbapap.2005.06.005
Kastritis PL, Bonvin AMJJ (2010) Are scoring functions in protein-protein docking ready to predict interactome? Clues from a novel binding affinity benchmark. J Proteome Res 9:2216–2225. https://doi.org/10.1021/pr9009854
Morris G, Fanucchi S (2016) A key evolutionary mutation enhances DNA binding of the FOXP2 forkhead domain. Biochemistry 55:1959–1967. https://doi.org/10.1021/acs.biochem.5b01271
Hellman L, Fried M (2007) Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid anteractions. Nat Protoc 2:1849–1861. https://doi.org/10.1038/nprot.2007.249.Electrophoretic
Sidorova NY, Hung S, Rau DC (2010) Stabilizing labile DNA-protein complexes in polyacrylamide gels. Electrophoresis 31:648–653. https://doi.org/10.1002/elps.200900573
Acknowledgements
This work was supported by the University of the Witwatersrand, South African National Research Foundation Grants 80681 and 68898 to S.F. and H.W.D. respectively, the South African Research Chairs Initiative of the Department of Science and Technology Grant 64788 to H.W.D., and the Medical Research Council of South Africa.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Blane, A., Dirr, H.W. & Fanucchi, S. A Phosphomimetic Study Implicates Ser557 in Regulation of FOXP2 DNA Binding. Protein J 37, 311–323 (2018). https://doi.org/10.1007/s10930-018-9777-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-018-9777-7
Keywords
- FOXP2
- Forkhead box
- Phosphorylation
- Post translational modification
- DNA binding
- Transcription regulation